G Protein Signaling Modulator-3 (GPSM3) is a leukocyte-specific regulator of G protein-coupled receptors (GPCRs), which binds inactivated Gα i ·GDP subunits and precludes their reassociation with Gβγ subunits. GPSM3 deficiency protects mice from inflammatory arthritis and, in humans, GPSM3 single-nucleotide polymorphisms (SNPs) are inversely associated with the risk of rheumatoid arthritis development; recently, these polymorphisms were linked to one particular SNP (rs204989) that decreases GPSM3 transcript abundance. However, the precise role of GPSM3 in leukocyte biology is unknown. Here, we show that GPSM3 is induced in the human promyelocytic leukemia NB4 cell line following retinoic acid treatment, which differentiates this cell line into a model of neutrophil physiology (NB4*). Reducing GPSM3 expression in NB4* cells, akin to the effect ascribed to the rs204989 C4T transition, disrupts cellular migration toward leukotriene B4 (LTB4) and (to a lesser extent) interleukin-8 (a.k.a. IL-8 or CXCL8), but not migration toward formylated peptides (fMLP). As the chemoattractants LTB4 and CXCL8 are involved in recruitment of neutrophils to the arthritic joint, our results suggest that the arthritis-protective GPSM3 SNP rs204989 may act to decrease neutrophil chemoattractant responsiveness.
INTRODUCTION
G Protein Signaling Modulator-3 (GPSM3) is a GoLoco motif protein 1,2 restricted in expression to mature monocytes, lymphocytes and neutrophils; recent expression quantitative trait locus analyses of stimulated primary monocytes 3 and peripheral blood CD16+ neutrophils 4 have identified human genomic sequence variations that impinge upon GPSM3 expression, including the single-nucleotide polymorphism (SNP) rs204990 (ref. 3) in a region directly upstream of the presumptive GPSM3 transcription start site. Independent, genome-wide association studies of sequence variations associated with autoimmune disease risk have highlighted additional GPSM3 SNPs as being inversely correlated (rs204989, rs204991) to the risk of developing rheumatoid arthritis (RA), ankylosing spondylitis, multiple sclerosis [5] [6] [7] and systemic lupus erythematosus. 8 GPSM3 polymorphisms are also associated with the risk of developing type 1 diabetes (rs204991; ref. 5 ), atopic dermatitis (rs176095; ref. 9 ) and childhood asthma (rs176095; ref. 10) . We recently reported 11 that SNPs rs204989, rs204990 and rs204991 constitute a haplotype block within which the rs204989 C4T transition is causal to reduced GPSM3 promoter activity. The association between a promoter-weakening GPSM3 SNP and reduced risk of RA is supported by the protection afforded to Gpsm3-deficient mice in an acute model of inflammatory arthritis. 12 Histologic analysis of synovial tissue from Gpsm3-deficient mice revealed a marked acellularity, 12 suggesting that their protection from developing pathologic inflammation relies on a potential cellular trafficking defect.
Neutrophils are leukocytes critical to the activation of inflammation in RA and many other autoimmune-related diseases (reviewed in Wright et al. 13 ). Neutrophils elicit this function following their initial recruitment by early-phase proinflammatory chemoattractants. In RA, this early-phase recruitment is mediated primarily by leukotriene B4 (LTB4), followed by a LTB4 positivefeedback loop in which recruited neutrophils secrete LTB4, CXCL8 and additional chemoattractants (reviewed in Sadik et al. 14 ) . To date, work to identify the role of GPSM3 in disease pathophysiology has exclusively focused on circulating monocytes, which compose less than 10% of circulating leukocytes. 15 However, mice made deficient in one of several monocyte chemokine receptors (that is, CCR1, CCR2 and CCR5) do not exhibit significant protection from models of RA inflammation; 16 furthermore, mice depleted of Ly6C high monocytes have no change in histological inflammation. 17 Moreover, the initial class of leukocytes recruited to synovial tissues in human arthritis is thought to be neutrophils, which migrate in response to a sequential cascade of LTB4, IL-1β and CXCR2 agonists. 14 Further support for the primary role of neutrophils in initiating RA inflammation comes from protection afforded to mouse strains that are deficient in various proteins required for the recognition or synthesis of LTB4, including the LTB4 receptor BLT1, 18 5-lipoxygenase activating protein, 19 5-lipoxygenase 20 and leukotriene A4 hydrolase. 20 The LTB4 receptor BLT1 and the CXCL8 receptors CXCR1 and CXCR2 are GPCRs linked to pertussis toxin-sensitive G i -subfamily heterotrimers, [21] [22] [23] and therefore sensitive to potential regulation by GoLoco motif-containing proteins (like GPSM3) that act as Gα i -selective guanine nucleotide dissociation inhibitors. 1 The role of GPSM3 in neutrophil function has not previously been assessed.
Here, we identify the expression of GPSM3 in an immortalized cell line that can be differentiated toward neutrophil-like function, and further identify a selective role for GPSM3 in its migration toward proinflammatory chemoattractants LTB4 and CXCL8-a discovery that helps strengthen the association between the promoterweakening GPSM3 SNP rs204989 and a reduced risk of RA.
RESULTS
GPSM3 expression is induced in all-trans retinoic aciddifferentiated NB4* cells GPSM3 protein expression was undetectable within whole-cell lysates of the human acute promyelocytic leukemia NB4 cell line. However, upon treatment of NB4 cell cultures with all-trans retinoic acid (ATRA), expression of GPSM3 transcript ( Figure 1a ) and encoded protein ( Figure 1b ) increased in a differentiationdependent manner concurrently with the established differentiation marker CD11b. This ATRA-dependent induction of GPSM3 expression also paralleled the acquisition of other markers of differentiated neutrophil function: specifically, the activity of intracellular oxidoreductase enzymes that can reduce nitroblue tetrazolium (NBT) to colored formazan dye ( Figure 1c ) and morphologic changes ( Figure 1d ; for example, invagination of the nucleus), both of which have been reported previously in ATRA-differentiated NB4* cells. 24 GPSM3 deficiency does not impair ATRA-induced differentiation of NB4 cells We established stable, monoclonal daughter lines from the parental NB4 cell line using previously validated short hairpin RNA (shRNA)-expressing lentiviral vectors directed against GPSM3. 25 After ATRA treatment, all daughter lines exhibited equivalent upregulation of CD11b and equivalent expression of Gβ subunits (Figure 2a , right panel); the latter result suggests that the established interaction between GPSM3 and neo-synthesized, free Gβ subunits 25 does not affect steady-state Gβ levels in this cell line. In addition, all daughter lines exhibited equivalent induction of intracellular oxidoreductase activity upon ATRA treatment (Figure 2b , right panel; Supplementary Table S1 ).
GPSM3 deficiency impairs migration toward LTB4 and CXCL8, but not fMLP NB4* monoclonal lines with successful knockdown of GPSM3 expression were observed to have negligible spontaneous migration behaviors (Supplementary Figure S1A ) and similar overall migratory responsiveness to 10% fetal bovine serum placed in the lower chamber of the Transwell apparatus (Supplementary Figure S1B ). However, the NB4* lines with reduced GPSM3 expression were found to have disrupted migration toward LTB4 and (to a lesser Figure S1 ). For example, compared with the scrambled shRNA control lines, only the NB4*-shRNA19.5 line exhibited a significant difference in LTB4R1 mRNA expression ( Figure 3a , inset, Δ = +56.5%, P = 0.0134) and this difference was an increase in expression.
DISCUSSION
Before its mRNA was cloned, 26 GPSM3 protein was first detected in neutrophil detergent-resistant fractions by mass spectrometry. 27 More recently, RNA-seq data sets indicate that human neutrophils have greater GPSM3 transcript expression than all other types of circulating leukocytes (for example, NCBI GEO accession number GSE62408. 28 These findings sparked our interest in determining whether GPSM3 regulates aspect(s) of neutrophil biology, especially in light of the GPSM3 SNP rs204989 being associated with decreased GPSM3 expression 11 and protection against the development of RA 5-7 -an autoimmune disease in which neutrophil function is central to its initiation. Using RNA interference to negate the GPSM3 upregulation found to occur normally in the promyelocytic NB4 cell line upon ATRA differentiation, we have now established that GPSM3 is required for the full migratory response of this neutrophil-like cell line toward a pathophysiologically relevant concentration of LTB4; 29 in addition, GPSM3 also appears to have a role in migratory responsiveness toward CXCL8, although only observed with the highest degree of GPSM3 deficiency (that is, the NB4*-shRNA19 monoclonal lines in which GPSM3 protein was barely detectable by immunoblotting). Migratory responses to LTB4 and CXCL8 are believed to be dependent on the relative abundance of GPSM3 protein in these cells, given that the NB4*-shRNA20 monoclonal lines 20.2 and 20.5 were seen to have an intermediate level of GPSM3 knockdown efficiency and, in parallel, an intermediate migratory phenotype toward LTB4 and no significant defect in migration toward CXCL8. Given the primary coupling of LTB4 and CXCL8 receptors to Gα icontaining heterotrimers [21] [22] [23] and the inhibitory influence exerted by the GoLoco motifs of GPSM3 on Gα i signaling and heterotrimer recycling, 26 reduced GPSM3 levels in NB4* cells likely increase the rate of inactive Gα i subunit reassociation with free Gβγ heterodimers. As signaling by the free Gβγ heterodimer is central to the migratory response, 22, 23 any accelerated deactivation by increased Gα i reassociation would lead to a diminished migration phenotype. Given the diminished NB4* cell line migration toward the RA-relevant chemoattractants LTB4 and CXCL8, we surmise that the synovial acellularity seen in anti-collagen antibody challenged GPSM3-deficient mice 12 and the inverse association between RA development and the GPSM3 expression-lowering SNP rs204989 (ref. 11) could be the result of reduced neutrophil recruitment by these particular chemoattractants.
During infections, neutrophil responsiveness to bacterialderived formylated peptides is mediated via formyl peptide receptors: 30 in a similar manner to LTB4 and CXCL8 receptors. However, GPSM3 knockdown in NB4* cells does not appear to affect migration initiated through the formyl peptide receptor. We therefore conclude that GPSM3 knockdown does not globally affect the chemotactic machinery of NB4* cells, but instead leads to a selective abrogation of responsiveness to certain chemoattractants, like LTB4 and CXCL8 shown here. Future investigations will be directed at identifying the specific signaling mechanism(s) regulated by GPSM3 that differentially affect LTB4-and CXCL8-vs fMLP-induced migration; one such mechanism might involve direct coupling by GPSM3 of Gα i subunits to select chemokineresponsive GPCRs (that is, in the absence of Gβγ subunits), as has been speculated on recently by Blumer and colleagues. 32 The effect of GPSM3 deficiency on NB4* LTB4-induced migration, coupled with the established role that LTB4 plays in the early pathogenesis of RA, supports the therapeutic potential of GPSM3targeted inhibitors in the treatment of RA, as we have proposed previously; 11 the potential to inhibit GPSM3 pharmacologically and thereby reduce neutrophil migration to the inflamed joint while sparing fMLP responsiveness is attractive as it suggests a means of reducing RA pathology without compromising responsiveness to bacterial infections.
MATERIALS AND METHODS

Cell lines and culture conditions
The human acute promyelocytic leukemia cell line (NB4) was obtained from the Leibniz Institute German Collection of Microorganisms and Cell Cultures. Preliminary studies were performed on NB4 cells that were a generous gift from Dr Sherman Weissman. Cells were maintained at 37°C in a humidified, 5% CO 2 atmosphere in an ATCC modification of RPMI medium supplemented with 10% heat-inactivated fetal bovine serum, 100 IU penicillin, 100 μg ml − 1 streptomycin and 2 μg ml − 1 puromycin. GPSM3 expression was stably knocked down via lentiviral transduction (WVU IBC protocol 15-04-08) as described previously. 11 The shRNA hairpin sequences for shRNA19 (TRC clone ID: TRCN0000036819), shRNA20 (TRCN000 0036820), and shRNA22 (TRCN0000036822) are available from The RNAi Consortium (http://www.broadinstitute.org/rnai/public) and listed in Supplementary Table S2 . Additional NB4 cell lines were established expressing a scrambled shRNA control (Addgene plasmid 1864), with the scrambled-hairpin sequence as reported by Addgene (https://www. addgene.org/1864/; listed in Supplementary Table S2 ). Lentiviral ransduction was performed at a multiplicity of infection of 10 using spinoculation; 33 transduced cells were selected with 2 μg ml − 1 puromycin and monoclonal populations established by limiting dilution. The resultant NB4 cell lines stably expressing GPSM3-targeted shRNA with the most effective knockdown of GPSM3 were selected for this study. One monoclonal cell line expressing the scrambled shRNA control ('scr1') was lost to poor growth under selection pressure. All NB4 lines were confirmed free of Mycoplasma spp. and Acholeplasma spp. contamination using the Lookout Mycoplasma PCR Detection kit (Sigma-Aldrich, St Louis, MO, USA; see Supplementary Figure S4 ). NB4 cell line differentiation was performed as previously reported 34 by treatment with complete media containing 1 μM ATRA (Acros Organics, Geel, Belgium). Cell density was maintained between 2 × 10 5 and 1 × 10 6 cells per ml.
NBT reduction
Cells (5 × 10 5 ) were resuspended in PBS with 1 mg ml − 1 NBT and 300 nM PMA, then incubated at 37°C and 5% CO 2 for 30 min. Cells were then washed in PBS twice and mounted on slides for visualization of 500 cells per cell population per experiment. Formazan-positive (black), -intermediate (gray) and -negative (colorless) cells were scored under brightfield microscopy. Investigator was blinded to the transgene status of each experimental condition.
Wright-Giemsa staining
Cells were fixed with 100% methanol for 1 min, then allowed to air-dry briefly. Cells were then stained using Wright-Giemsa stain for 2 min, after which 1.5 volumes of PBS, pH 6.8 was added, and the cells were allowed to incubate for another 2 min. Cells were washed and visualized on an EVOS FL Auto microscope (Thermo Scientific, Waltham, MA, USA).
Complementary DNA synthesis and quantitative reverse transcriptase PCR RNA was extracted from ATRA-differentiated NB4* cells with the RNeasy kit (Qiagen, Hilden, Germany). Briefly, cells were centrifuged at 200 g for 5 min, and the supernatant was removed. Cells were then washed with 1 × PBS and centrifuged again to remove supernatant. The cell pellet was resuspended in 600 μl of the manufacturer's lysis buffer (buffer RLT, Qiagen) with 1% β-mercaptoethanol. RNA isolation was performed using an automated QIAcube workflow according to the manufacturer's suggested protocol to minimize the variability between preparations. Eluted nucleic acids were quantified by absorbance at 260 nm using a Nanodrop 2000 (Thermo Scientific) and assessed for purity using a 260/280 nm cutoff ratio of ≥ 1.8. Immediately following isolation, a sample of eluted nucleic acids (250 ng) from each group of cells was used to synthesize cDNA (complementary DNA) with the Thermo Verso Reverse Transcriptase Kit (Thermo Scientific). cDNA was then diluted 1:5 and used immediately for quantitative reverse transcriptase PCR analyses. Samples of cDNA, derived from equal mass of input RNA from each sample, were amplified in duplicate (with an additional, independent, 'no reverse transcriptase-treated' control) using the USB VeriQuest Fast SYBR Green qPCR Master Mix (Affymetrix, Cleveland, OH, USA) and commercially-validated PCR primers (Qiagen). Cycling conditions were established following the manufacturer's suggested protocol. Relative quantification of gene expression was performed using the ΔΔC T method 35 with β-microglobulin chosen as the stable housekeeping gene. Primer sequences for GPSM3 and β-microglobulin were as previously described; 11 all other primer pairs were procured from Qiagen.
Transwell migration assay
shRNA-expressing NB4 cell lines were serum-starved in HBSS+1% BSA at 37°C for 1 h and labeled with calcein-AM cell-permeant fluorescent dye 
Antibodies and western blot
Antibodies targeting GPSM3 (UNC Immunology Core; clone 35.5.1; 1:200 dilution), CD11b (Developmental Studies Hybridoma Bank; clone H5A4; 1:200 dilution), pan-Gbeta (T-20 (cat# sc-378); Santa Cruz Biotechnology; 1:500 dilution) and β-actin (Sigma (cat# A3854); 1:2000 dilution) were purchased from the indicated sources. Horseradish peroxidase (HRP)conjugated anti-mouse IgG was purchased from Sigma. Cells were lysed with ice-cold RIPA buffer with protease inhibitor (Thermo Scientific), sonicated on ice, then clarified by centrifugation at 20 000 g for 5 min. Protein content was quantified by the Bradford protein assay (Thermo Scientific) using BSA as a standard. Lysates were diluted in Laemmli buffer (Bio-Rad, Hercules, CA, USA) and resolved on 8-16% pre-cast SDS-polyacyrlamide gels (Bio-Rad), transferred onto nitrocellulose membranes, immunoblotted with primary (overnight, 4°C) and horseradish peroxidase-conjugated secondary (1:2000 dilution, 2 h at room temperature) antibodies, and visualized by chemiluminescence (ECL, Thermo Scientific).
Statistical analyses
Regression analyses of Transwell migration assay data were performed using four parameter logistic non-linear regression analyses over the first 30-min period of migration with post hoc comparison by F-test to confirm whether one model adequately represents all data sets. Analyses were confirmed to accept the null hypothesis of the Shapiro-Wilk normality test (Po0.05). Statistical analyses including initial rate determinations were performed in GraphPad Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA) using one-way ANOVA with Bonferroni or Dunnett's post hoc tests where indicated.
